Related Experiment Video
Updated: Mar 27, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.4K
[Regulators in access to anticancer drugs in Canada]
Sante Publique (Vandoeuvre-Les-Nancy, France)
|January 12, 2016
Summary
Provincial drug plans do not guarantee access to anticancer drugs (ACD). Regulatory differences significantly impact patient access, though less critical treatments are most affected.
Area of Science:
- Health Policy
- Pharmaceutical Access
- Canadian Healthcare System
Context:
- Provincial public health insurance systems in Canada provide drug coverage.
- Previous studies highlighted variability in anticancer drug (ACD) access.
- Concerns exist regarding equitable access to essential cancer treatments.
Purpose:
- To evaluate the impact of provincial regulatory frameworks on anticancer drug (ACD) accessibility.
- To determine if public drug plan listing accurately reflects patient availability of ACDs.
- To compare regulatory strategies across Canadian provinces influencing drug access.
Summary:
- This study analyzes provincial regulators affecting public health insurance access to anticancer drugs (ACD).
- Regulators include conditions for public insurance access and third-party payer management strategies.
- Variability in ACD access exists across provinces, primarily affecting non-essential therapies.
Impact:
- Highlights that drug listing alone is insufficient to ensure patient access to ACDs.
- Reveals significant provincial disparities in regulatory approaches to drug management.
- Suggests that policy interventions may be needed to improve equitable access to essential cancer drugs.
More Related Videos
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
9.3K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.6K
Related Concept Videos
01:25Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.8K
1.8K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
648
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
648